Intra-aortic balloon pump in intensive cardiac care: a registry in Florence
| Autor: | Marco Chiostri, Serafina Valente, Gian Franco Gensini, Cristina Giglioli, Chiara Lazzeri, Mery Zucchini |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
medicine.medical_specialty
Ejection fraction Intra-Aortic Balloon Pumping Critical Care business.industry medicine.medical_treatment Cardiogenic shock Incidence Shock Cardiogenic Percutaneous coronary intervention medicine.disease Coronary artery disease Italy Intensive care Internal medicine medicine Cardiology Humans Myocardial infarction Registries Cardiology and Cardiovascular Medicine business Intra-aortic balloon pump Killip class |
| Zdroj: | International journal of cardiology. 146(2) |
| ISSN: | 1874-1754 |
| Popis: | The Intra-aortic Balloon Pump (IABP) is currently the most commonly used mechanical assist device to improve and support hemodynamics in patients with cardiogenic shock; it is widely used also in high-risk patients undergoing percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) [1–9]. However, the impact of IABP on prognosis is so far controversial [5,10]. We assessed the in-hospital mortality and complications in patients treated with IABP consecutively admitted to our Intensive Cardiac Care Unit (ICCU). From Jan. 1, 2005 to Dec. 31, 2008, 3500 patients were consecutively admitted to our ICCU [11–13]. Among them, 414 (11.8%) underwent IABP during their hospitalization and were prospectively enrolled in our Registry. Large ischemic risk area (LIRA)was defined as “ejection fraction less than 40% together with proximal occlusion of left descending anterior coronary artery associated or not with critical lesions in other coronary arteries”. In these patients IABP was deployed after PCI. Patients were defined as “high risk” as if one ormore of the following criteria were present: ventricular ejection fraction (LVEF) |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect